These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 12151419)

  • 1. Should patients with polycystic ovarian syndrome be treated with metformin?: an enthusiastic endorsement.
    Nestler JE
    Hum Reprod; 2002 Aug; 17(8):1950-3. PubMed ID: 12151419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance.
    Arslanian SA; Lewy V; Danadian K; Saad R
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1555-9. PubMed ID: 11932281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance, polycystic ovary syndrome and metformin.
    Pugeat M; Ducluzeau PH
    Drugs; 1999; 58 Suppl 1():41-6; discussion 75-82. PubMed ID: 10576524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should insulin-sensitizing drugs be used in the treatment of polycystic ovary syndrome?
    Cheang KI; Nestler JE
    Reprod Biomed Online; 2004 Apr; 8(4):440-7. PubMed ID: 15149568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance and metformin in polycystic ovary syndrome.
    Ben-Haroush A; Yogev Y; Fisch B
    Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):125-33. PubMed ID: 15262344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should patients with polycystic ovarian syndrome be treated with metformin?
    Seli E; Duleba AJ
    Hum Reprod; 2002 Sep; 17(9):2230-6. PubMed ID: 12202407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study.
    Morin-Papunen L; Vauhkonen I; Koivunen R; Ruokonen A; Martikainen H; Tapanainen JS
    J Clin Endocrinol Metab; 2003 Jan; 88(1):148-56. PubMed ID: 12519844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?
    Franks S
    Clin Endocrinol (Oxf); 2011 Feb; 74(2):148-51. PubMed ID: 21121941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular action of insulin-sensitizing agents].
    Kacalska O; Krzyczkowska-Sendrakowska M; Milewicz T; Zabińska-Popiela M; Bereza T; Krzysiek-Maczka G; Krzysiek J
    Endokrynol Pol; 2005; 56(3):308-13. PubMed ID: 16350724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revisit of metformin treatment in polycystic ovarian syndrome.
    Lam PM; Cheung LP; Haines C
    Gynecol Endocrinol; 2004 Jul; 19(1):33-9. PubMed ID: 15625771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycystic ovary syndrome in adolescents.
    Kent SC; Legro RS
    Adolesc Med; 2002 Feb; 13(1):73-88, vi. PubMed ID: 11841956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycystic ovary syndrome and metabolic comorbidities: therapeutic options.
    De Leo V; Musacchio MC; Palermo V; Di Sabatino A; Morgante G; Petraglia F
    Drugs Today (Barc); 2009 Oct; 45(10):763-75. PubMed ID: 20069140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin and intervention in polycystic ovary syndrome. Endocrine Society of Australia, the Australian Diabetes Society and the Australian Paediatric Endocrine Group.
    Norman RJ; Kidson WJ; Cuneo RC; Zacharin MR
    Med J Aust; 2001 Jun; 174(11):580-3. PubMed ID: 11453331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polycystic ovary syndrome.
    Ehrmann DA
    N Engl J Med; 2005 Mar; 352(12):1223-36. PubMed ID: 15788499
    [No Abstract]   [Full Text] [Related]  

  • 15. Polycystic ovary syndrome (PCOS) and the accompanying disorders of glucose homeostasis among girls at the time of puberty.
    Otto-Buczkowska E; Grzyb K; Jainta N
    Pediatr Endocrinol Diabetes Metab; 2018; 24(1):40-44. PubMed ID: 30083660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin and other insulin sensitizers in polycystic ovary syndrome.
    Bhagavath B; Vitek W; Queenan J; Hoeger K
    Semin Reprod Med; 2014 Jul; 32(4):323-30. PubMed ID: 24919033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of diabetes and cardiovascular disease in women with PCOS: treatment with insulin sensitizers.
    Sharma ST; Nestler JE
    Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):245-60. PubMed ID: 16772155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study.
    Morin-Papunen LC; Vauhkonen I; Koivunen RM; Ruokonen A; Martikainen HK; Tapanainen JS
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3161-8. PubMed ID: 10999803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Insulin resistance in polycystic ovary syndrome].
    Schröder AK; Tauchert S; Ortmann O; Diedrich K; Weiss JM
    Wien Klin Wochenschr; 2003 Dec; 115(23):812-21. PubMed ID: 14740344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should patients with polycystic ovary syndrome be treated with metformin? Benefits of insulin sensitizing drugs in polycystic ovary syndrome--beyond ovulation induction.
    Stadtmauer LA; Wong BC; Oehninger S
    Hum Reprod; 2002 Dec; 17(12):3016-26. PubMed ID: 12456596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.